Effects of motexafin gadolinium on DNA damage and X-ray-induced DNA damage repair, as assessed by the Comet assay
- PMID: 15990023
- DOI: 10.1016/j.ijrobp.2005.04.014
Effects of motexafin gadolinium on DNA damage and X-ray-induced DNA damage repair, as assessed by the Comet assay
Abstract
Purpose: To investigate the effects of motexafin gadolinium (MGd) on the levels of reactive oxygen species (ROS), glutathione (GSH), and DNA damage in EMT6 mouse mammary carcinoma cells. The ability of MGd to alter radiosensitivity and to inhibit DNA damage repair after X-ray irradiation was also evaluated.
Methods and materials: Reactive oxygen species and GSH levels were assessed by 2,7-dichlorofluorescein fluorescence flow cytometry and the Tietze method, respectively. Cellular radiosensitivity was assessed by clonogenic assays. Deoxyribonucleic acid damage and DNA damage repair were assessed in plateau-phase EMT6 cells by the Comet assay and clonogenic assays.
Results: Cells treated with 100 mumol/L MGd plus equimolar ascorbic acid (AA) had significantly increased levels of ROS and a 58.9% +/- 3.4% decrease in GSH levels, relative to controls. Motexafin gadolinium plus AA treatment increased the hypoxic, but not the aerobic, radiosensitivity of EMT6 cells. There were increased levels of single-strand breaks in cells treated with 100 mumol/L MGd plus equimolar AA, as evidenced by changes in the alkaline tail moment (MGd + AA, 6 h: 14.7 +/- 1.8; control: 2.8 +/- 0.9). The level of single-strand breaks was dependent on the length of treatment. Motexafin gadolinium plus AA did not increase double-strand breaks. The repair of single-strand breaks at 2 h, but not at 4 h and 6 h, after irradiation was altered significantly in cells treated with MGd plus AA (MGd + AA, 2 h: 15.8 +/- 3.4; control: 5.8 +/- 0.6). Motexafin gadolinium did not alter the repair of double-strand breaks at any time after irradiation with 10 Gy.
Conclusions: Motexafin gadolinium plus AA generated ROS, which in turn altered GSH homeostasis and induced DNA strand breaks. The MGd plus AA-mediated alteration of GSH levels increased the hypoxic, but not aerobic, radiosensitivity of EMT6 cells. Motexafin gadolinium altered the kinetics of single-strand break repair soon after irradiation but did not inhibit potentially lethal damage repair in EMT6 cells.
Similar articles
-
Radiosensitivity, apoptosis and repair of DNA double-strand breaks in radiation-sensitive Chinese hamster ovary cell mutants treated at different dose rates.Radiat Res. 1996 Dec;146(6):636-45. Radiat Res. 1996. PMID: 8955713
-
Relationship between cellular radiosensitivity and DNA damage measured by comet assay in human normal, NBS and AT fibroblasts.Int J Radiat Biol. 2001 Sep;77(9):929-38. doi: 10.1080/09553000110064222. Int J Radiat Biol. 2001. PMID: 11576452
-
Motexafin gadolinium: a redox active drug that enhances the efficacy of bleomycin and doxorubicin.Clin Cancer Res. 2001 Oct;7(10):3215-21. Clin Cancer Res. 2001. PMID: 11595717
-
The role of DNA single- and double-strand breaks in cell killing by ionizing radiation.Radiat Res. 1998 Nov;150(5 Suppl):S42-51. Radiat Res. 1998. PMID: 9806608 Review.
-
Genotoxicity of environmental agents assessed by the alkaline comet assay.Basic Clin Pharmacol Toxicol. 2005;96 Suppl 1:1-42. Basic Clin Pharmacol Toxicol. 2005. PMID: 15859009 Review.
Cited by
-
Patterns of persistent DNA damage associated with sun exposure and the glutathione S-transferase M1 genotype in melanoma patients.Photochem Photobiol. 2009 Jan-Feb;85(1):379-86. doi: 10.1111/j.1751-1097.2008.00455.x. Photochem Photobiol. 2009. PMID: 19161404 Free PMC article.
-
Lanthanides: Applications in Cancer Diagnosis and Therapy.J Med Chem. 2016 Jul 14;59(13):6012-24. doi: 10.1021/acs.jmedchem.5b01975. Epub 2016 Feb 19. J Med Chem. 2016. PMID: 26862866 Free PMC article.
-
Phase I trial of motexafin gadolinium and doxorubicin in the treatment of advanced malignancies.Invest New Drugs. 2011 Apr;29(2):316-22. doi: 10.1007/s10637-009-9364-z. Epub 2009 Dec 9. Invest New Drugs. 2011. PMID: 19997959 Free PMC article. Clinical Trial.
-
Do Gadolinium-Based Contrasts Represent a High Risk for Genotoxicity in Mammalian Cells? A Systematic Review.J Appl Toxicol. 2025 Oct;45(10):1935-1946. doi: 10.1002/jat.4814. Epub 2025 May 28. J Appl Toxicol. 2025. PMID: 40437732 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical